Nasdaq:US$34.13 (+0.27) | HKEX:HK$55.30 (+0.30) | AIM:£5.14 (+0)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 9 Oct 2013

Chi-Med’s Pharmaceutical R&D Business – Analyst & Investor Briefing